Role of Intestinal Transit in the Pathogenesis of Gallbladder Stones

Increasing evidence implicates prolonged intestinal transit (slow transit constipation) in the pathogenesis of conventional gallbladder stones (GBS), and that of gallstones induced by long...

Full description

Saved in:
Bibliographic Details
Main Authors: R Hermon Dowling, Martin J Veysey, Stephen P Pereira, S Hyder Hussaini, Linzi A Thomas, John AH Wass, Gerard M Murphy
Format: Article
Language:English
Published: Wiley 1997-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/1997/532036
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552999298269184
author R Hermon Dowling
Martin J Veysey
Stephen P Pereira
S Hyder Hussaini
Linzi A Thomas
John AH Wass
Gerard M Murphy
author_facet R Hermon Dowling
Martin J Veysey
Stephen P Pereira
S Hyder Hussaini
Linzi A Thomas
John AH Wass
Gerard M Murphy
author_sort R Hermon Dowling
collection DOAJ
description Increasing evidence implicates prolonged intestinal transit (slow transit constipation) in the pathogenesis of conventional gallbladder stones (GBS), and that of gallstones induced by long term octreotide (OT) treatment. Both groups of GBS patients have multiple abnormalities in the lipid composition and physical chemistry of their gallbladder bile - associated with, and possibly due to, an increased proportion of deoxycholic acid (DCA) (percentage of total bile acids). In turn, this increase in the percentage of DCA seems to be a consequence of prolonged colonic transit. Thus, in acromegalic patients OT treatment significantly prolongs large bowel transit time (LBTT) and leads to an associated increase of the percentage of DCA in fasting serum (and, by implication, in gallbladder bile). LBTT is linearly related to the percentage of DCA in fasting serum and correlates significantly with DCA input (into the enterohepatic circulation) and DCA pool size. However, these adverse effects of OT can be overcome by the concomitant use of the prokinetic drug cisapride, which normalizes LBTT and prevents the rise in the percentage of serum DCA. Therefore, in OT-treated patients and other groups at high risk of developing stones, it may be possible to prevent GBS formation with the use of intestinal prokinetic drugs.
format Article
id doaj-art-a24e6a3e046c4b00ac5c8a30ca8c9f32
institution Kabale University
issn 0835-7900
language English
publishDate 1997-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-a24e6a3e046c4b00ac5c8a30ca8c9f322025-02-03T05:57:10ZengWileyCanadian Journal of Gastroenterology0835-79001997-01-01111576410.1155/1997/532036Role of Intestinal Transit in the Pathogenesis of Gallbladder StonesR Hermon Dowling0Martin J Veysey1Stephen P Pereira2S Hyder Hussaini3Linzi A Thomas4John AH Wass5Gerard M Murphy6Gastroenterology Unit, Guy’s Hospital & Campus, UMDS of Guy’s & St Thomas’ Hospital, London, UKGastroenterology Unit, Guy’s Hospital & Campus, UMDS of Guy’s & St Thomas’ Hospital, London, UKGastroenterology Unit, Guy’s Hospital & Campus, UMDS of Guy’s & St Thomas’ Hospital, London, UKGastroenterology Unit, Guy’s Hospital & Campus, UMDS of Guy’s & St Thomas’ Hospital, London, UKGastroenterology Unit, Guy’s Hospital & Campus, UMDS of Guy’s & St Thomas’ Hospital, London, UKDepartment of Endocrinology, John Radcliffe Hospital and Oxford University, Oxford, UKGastroenterology Unit, Guy’s Hospital & Campus, UMDS of Guy’s & St Thomas’ Hospital, London, UKIncreasing evidence implicates prolonged intestinal transit (slow transit constipation) in the pathogenesis of conventional gallbladder stones (GBS), and that of gallstones induced by long term octreotide (OT) treatment. Both groups of GBS patients have multiple abnormalities in the lipid composition and physical chemistry of their gallbladder bile - associated with, and possibly due to, an increased proportion of deoxycholic acid (DCA) (percentage of total bile acids). In turn, this increase in the percentage of DCA seems to be a consequence of prolonged colonic transit. Thus, in acromegalic patients OT treatment significantly prolongs large bowel transit time (LBTT) and leads to an associated increase of the percentage of DCA in fasting serum (and, by implication, in gallbladder bile). LBTT is linearly related to the percentage of DCA in fasting serum and correlates significantly with DCA input (into the enterohepatic circulation) and DCA pool size. However, these adverse effects of OT can be overcome by the concomitant use of the prokinetic drug cisapride, which normalizes LBTT and prevents the rise in the percentage of serum DCA. Therefore, in OT-treated patients and other groups at high risk of developing stones, it may be possible to prevent GBS formation with the use of intestinal prokinetic drugs.http://dx.doi.org/10.1155/1997/532036
spellingShingle R Hermon Dowling
Martin J Veysey
Stephen P Pereira
S Hyder Hussaini
Linzi A Thomas
John AH Wass
Gerard M Murphy
Role of Intestinal Transit in the Pathogenesis of Gallbladder Stones
Canadian Journal of Gastroenterology
title Role of Intestinal Transit in the Pathogenesis of Gallbladder Stones
title_full Role of Intestinal Transit in the Pathogenesis of Gallbladder Stones
title_fullStr Role of Intestinal Transit in the Pathogenesis of Gallbladder Stones
title_full_unstemmed Role of Intestinal Transit in the Pathogenesis of Gallbladder Stones
title_short Role of Intestinal Transit in the Pathogenesis of Gallbladder Stones
title_sort role of intestinal transit in the pathogenesis of gallbladder stones
url http://dx.doi.org/10.1155/1997/532036
work_keys_str_mv AT rhermondowling roleofintestinaltransitinthepathogenesisofgallbladderstones
AT martinjveysey roleofintestinaltransitinthepathogenesisofgallbladderstones
AT stephenppereira roleofintestinaltransitinthepathogenesisofgallbladderstones
AT shyderhussaini roleofintestinaltransitinthepathogenesisofgallbladderstones
AT linziathomas roleofintestinaltransitinthepathogenesisofgallbladderstones
AT johnahwass roleofintestinaltransitinthepathogenesisofgallbladderstones
AT gerardmmurphy roleofintestinaltransitinthepathogenesisofgallbladderstones